Rezolve Ai Calls Commerce.com's Q2 a Validation of Its Merger Case — Flat Revenue, Guidance Cut, and a 34% Stock Plunge
RZLV sits 28% above its 52-week low of $2.05.
Summary
Rezolve Ai seized on Commerce.com's weak Q2 — flat revenue, margin compression, and guidance cuts — to reinforce its case for a strategic combination, contrasting Commerce.com's stagnation with its own explosive growth. Commerce.com shares fell 34% pre-market.
Key Events · M&A and Partnerships · RZLV
-
Commerce.com Q2 Results Deteriorate
Revenue of $84.5M grew just 0.1% YoY; subscription revenue declined 1%; GAAP gross margin fell to 75% from 79%; free cash flow collapsed to $0.1M from $11.9M a year ago.
-
Full-Year Guidance Slashed
Commerce.com cut FY26 revenue guidance to $336.5M–$344.5M (from $347.5M–$369.5M) and non-GAAP operating income to $28M–$34M (from $34M–$53M), implying flat to declining full-year revenue.
-
Rezolve Ai Contrasts Explosive Growth
Rezolve expects H1 2026 revenue of ~$127M (nearly 20x YoY) and reaffirmed ~$360M FY26 guidance, now exceeding Commerce.com's reduced top-end range.
-
Market Punishes Commerce.com
Commerce.com shares fell ~34% in pre-market trading to ~$2.24 following the results, reflecting investor disappointment with the standalone strategy.
Analysis · RZLV · Technology
Commerce.com's Q2 results — flat revenue, declining subscriptions, collapsing free cash flow, and sharply reduced guidance — directly support Rezolve Ai's argument that the standalone strategy is failing. Rezolve contrasts this with its own nearly 20x H1 growth and reaffirmed $360M outlook, which now exceeds Commerce.com's reduced full-year range. The 34% pre-market drop in Commerce.com shares underscores the market's negative reaction. While Rezolve is not making a new offer, it signals that any future deal would be on worse terms for Commerce.com shareholders, raising the stakes for both companies.
At the time of this filing, RZLV was trading at $2.63 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $2.05 to $8.45. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.